Brexit Impact on UK-EU GMP Inspection Alignment

digi — Wed, 11 Jun 2025 23:43:14 +0000

Brexit Impact on UK-EU GMP Inspection Alignment Brexit and Its Impact on UK-EU GMP Inspection Alignment The UK’s departure from the European Union has significantly altered the pharmaceutical regulatory landscape, especially regarding Good Manufacturing Practice (GMP) inspections. Prior to Brexit, the UK operated within the EU regulatory framework coordinated by the European Medicines Agency (EMA)....

UK standalone GMP policy – Pharma GMP

Brexit Impact on UK-EU GMP Inspection Alignment